Jiangsu, China

Junjian Liu


 

 

Average Co-Inventor Count = 4.7

ph-index = 1

Forward Citations = 5(Granted Patents)


Location History:

  • Suzhou, CN (2022)
  • Jiangsu, CN (2021 - 2023)

Company Filing History:


Years Active: 2021-2025

Loading Chart...
Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents

Title: Junjian Liu: A Pioneer in Immunotherapy Innovations

Introduction

Junjian Liu is a notable inventor based in Jiangsu, China, recognized for his contributions to the field of immunotherapy. With a remarkable portfolio of 12 patents, he stands out as a significant figure in biotechnology, focusing on innovative therapeutic approaches to treat diverse diseases.

Latest Patents

Among Junjian Liu's most recent inventions are two groundbreaking patents. The first, titled "Interleukin-2 and use thereof," comprises a novel interleukin-2 (IL-2) mutant protein engineered for enhanced therapeutic efficacy. This innovative protein features reduced IL-2Rα receptor binding capability and increased binding ability to IL-2Rβ compared to the wild-type IL-2. Additionally, the invention encompasses a fusion protein, immunoconjugate, and methods for its preparation.

The second patent, "Anti-IL-23p19 antibody and use thereof in treating diseases," addresses the creation of a distinct antibody and antibody fragment that specifically targets IL-23p19. This patent includes a nucleic acid sequence encoding the antibody, a host cell for its production, and details on its therapeutic and diagnostic applications.

Career Highlights

Junjian Liu's career has been marked by significant roles at prominent companies in the biotechnology sector. He has worked with Innovent Biologics (Suzhou) Co., Ltd. and Nanjing Iaso Biotherapeutics Co., Ltd., where he has contributed his expertise toward developing innovative treatments that aim to revolutionize patient care.

Collaborations

Throughout his career, Junjian Liu has collaborated with talented professionals, including esteemed colleagues Bingliang Chen and Xiaoniu Miao. These partnerships have fostered an environment of creativity and knowledge sharing, enhancing the potential for groundbreaking innovations in their field.

Conclusion

With his impressive track record and commitment to advancing immunotherapeutic solutions, Junjian Liu continues to be a key player in the biotech industry. His inventive spirit and collaboration with like-minded professionals underscore the significance of his contributions to modern medicine, making him a distinguished inventor deserving of recognition.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…